These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies. Shawana S; Kehar SI; Masood S; Aamir I J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of phophatase and tensin homologue in normal, hyperplastic and neoplastic endometrium. Shawana S; Kehar SI; Shaikh F J Pak Med Assoc; 2014 Oct; 64(10):1103-8. PubMed ID: 25823145 [TBL] [Abstract][Full Text] [Related]
4. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma. Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685 [TBL] [Abstract][Full Text] [Related]
5. PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer? Travaglino A; Raffone A; Saccone G; Mascolo M; Pignatiello S; Mollo A; De Placido G; Insabato L; Zullo F APMIS; 2019 Apr; 127(4):161-169. PubMed ID: 30803040 [TBL] [Abstract][Full Text] [Related]
6. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Maxwell GL; Risinger JI; Gumbs C; Shaw H; Bentley RC; Barrett JC; Berchuck A; Futreal PA Cancer Res; 1998 Jun; 58(12):2500-3. PubMed ID: 9635567 [TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia. Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805 [TBL] [Abstract][Full Text] [Related]
8. Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia. Sun H; Enomoto T; Shroyer KR; Ozaki K; Fujita M; Ueda Y; Nakashima R; Kuragaki C; Ueda G; Murata Y Diagn Mol Pathol; 2002 Dec; 11(4):204-11. PubMed ID: 12459636 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index. Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031 [TBL] [Abstract][Full Text] [Related]
10. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia. Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618 [TBL] [Abstract][Full Text] [Related]
11. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression. Baak JP; Van Diermen B; Steinbakk A; Janssen E; Skaland I; Mutter GL; Fiane B; Løvslett K Hum Pathol; 2005 May; 36(5):555-61. PubMed ID: 15948123 [TBL] [Abstract][Full Text] [Related]
12. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population. Kanaya T; Kyo S; Sakaguchi J; Maida Y; Nakamura M; Takakura M; Hashimoto M; Mizumoto Y; Inoue M Am J Clin Pathol; 2005 Jul; 124(1):89-96. PubMed ID: 15923161 [TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia]. Taranger-Charpin C; Carpentier S; Dales JP; Garcia S; Djemli A; Andrac L; Lavaut MN; Sferlazzo K; Boubli L Bull Acad Natl Med; 2004; 188(3):415-27; discussion 427-9. PubMed ID: 15584653 [TBL] [Abstract][Full Text] [Related]
14. Involution of PTEN-null endometrial glands with progestin therapy. Zheng W; Baker HE; Mutter GL Gynecol Oncol; 2004 Mar; 92(3):1008-13. PubMed ID: 14984979 [TBL] [Abstract][Full Text] [Related]
15. Expression of PAX2 and PTEN Correlates to Therapy Response in Endometrial Hyperplasia. Ørbo A; Arnes M; Lyså LM; Straume B Anticancer Res; 2015 Dec; 35(12):6401-9. PubMed ID: 26637849 [TBL] [Abstract][Full Text] [Related]
16. PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma. Pavlakis K; Messini I; Vrekoussis T; Panoskaltsis T; Chrissanthakis D; Yiannou P; Stathopoulos EN Gynecol Oncol; 2010 Dec; 119(3):516-9. PubMed ID: 20833413 [TBL] [Abstract][Full Text] [Related]
17. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge. Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical reaction of the glandular epithelium in endometrial hyperplasia compared to endometrial carcinoma. Stoenescu VE; Niculescu M; Novac L; Manolea MM; Tomescu PI; Dijmărescu AL; Novac MB; Tudorache Ş; Iliescu DG Rom J Morphol Embryol; 2017; 58(3):791-800. PubMed ID: 29250656 [TBL] [Abstract][Full Text] [Related]
19. [Correlations between the ultrasound aspects of endometrial hyperplasias and the pathological exam]. Abushab S; Butureanu S; Cotuţiu C; Flaişer C Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):669-72. PubMed ID: 18293698 [TBL] [Abstract][Full Text] [Related]